Acquisition of a new primary healthcare centre

RNS Number : 6756B
The MedicX Fund Limited
08 January 2015
 



 

For immediate release

08 January 2015

 

MedicX Fund Limited

("MedicX Fund", "the Fund" or "the Company")

 

Acquisition of a new primary healthcare centre

 

MedicX Fund, (LSE: MXF), the specialist primary care infrastructure investor in modern, purpose-built, primary healthcare properties in the United Kingdom, is pleased to announce that it has contracted to acquire, by way of a forward commitment, a new primary healthcare medical centre at Palace Road, Streatham in South London.  The property is due to be completed in December 2015. 

The property will be let to a GP practice and a pharmacy, both of whom will take 21 year leases from practical completion subject to three-yearly, effectively upwards only rent reviews, with the pharmacy being indexed to RPI.  The total acquisition cost of the property is £2.92 million.

The MedicX Fund's total property portfolio now comprises 140 properties throughout the United Kingdom of which 131 are operational and fully let, with nine under construction. The annualised rent roll for all properties is now £33.7 million.

 

- End -

 

For further information please contact:

 

MedicX Fund                                                                   +44 (0) 1481 723 450

David Staples, Chairman

 

Octopus Healthcare Group                                                +44 (0) 1483 869 500

Mike Adams, Chief Executive Officer

Mark Osmond, Chief Financial Officer

 

Canaccord                                                                       +44 (0) 20 7466 5000

Andrew Zychowski/Helen Goldsmith

 

Buchanan                                                                        +44 (0) 20 7466 5000

Charles Ryland/Sophie McNulty

  

 

Information on MedicX Fund Limited

 

MedicX Fund Limited ("MXF", "MedicX Fund", "the Fund" or "the Company", or together with its subsidiaries, the "Group") is the specialist primary care infrastructure investor in modern, purpose-built primary healthcare properties in the United Kingdom, listed on the London Stock Exchange, with a portfolio comprising 140 properties.

The Investment Adviser to the Company is Octopus Healthcare Adviser Ltd, which is authorised and regulated by the Financial Conduct Authority and is a subsidiary of the Octopus Healthcare Group.  The Octopus Healthcare Group is a specialist investor, developer and manager of healthcare properties with 34 people operating across the UK.

 

The Company's website address is www.medicxfund.com. Neither the contents of the Company's website nor the contents of any website accessible from hyperlinks on the Company's website (or any other website) nor the contents of any website accessible from hyperlinks within this announcement, are incorporated into, or forms part of, this announcement.

 


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
ACQLVLFBEFFZBBF
UK 100

Latest directors dealings